Cargando…
Endothelial progenitor cells: what use for the cardiologist?
Endothelial Progenitor Cells (EPC) were first described in 1997 and have since been the subject of numerous investigative studies exploring the potential of these cells in the process of cardiovascular damage and repair. Whilst their exact definition and mechanism of action remains unclear, they are...
Autores principales: | Siddique, Aurangzeb, Shantsila, Eduard, Lip, Gregory YH, Varma, Chetan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834645/ https://www.ncbi.nlm.nih.gov/pubmed/20298532 http://dx.doi.org/10.1186/2040-2384-2-6 |
Ejemplares similares
-
Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?
por: Shantsila, Eduard, et al.
Publicado: (2016) -
'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications?
por: Shantsila, Eduard, et al.
Publicado: (2008) -
Emerging Tools for Stroke Prevention in Atrial Fibrillation
por: Voukalis, Christos, et al.
Publicado: (2016) -
Role of Monocytes in Heart Failure and Atrial Fibrillation
por: Shahid, Farhan, et al.
Publicado: (2018) -
Predictors of diastolic dysfunction in ethnic groups: Observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)
por: Shantsila, Alena, et al.
Publicado: (2018)